OSENI 12.5/45 12.5 mg alogliptin (as benzoate) / 45 mg pioglitazone (as hydrochloride) film-coated tablet bottle
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
26-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
alogliptin benzoate,pioglitazone hydrochloride
Available from:
Takeda Pharmaceuticals Australia Pty Ltd
INN (International Name):
Alogliptin benzoate,Pioglitazone hydrochloride
Authorization status:
Registered
